Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Escaned

Showing results (271-280 of 685) with videos related to

Pageof 69
Sort By:
Journal of Cardiovascular Translational Research|April 23, 2016
Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI StudyGladys N Janssens, Maarten A H van Leeuwen, Nina W van der Hoeven, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 27, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Trends in Cardiovascular Medicine|November 3, 2021
Optical coherence tomography and coronary revascularization: from indication to procedural optimizationRick Volleberg, Jan-Quinten Mol, Dirk van der Heijden, et al.
European Heart Journal|October 12, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
JACC. Asia|November 7, 2022
Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous Coronary InterventionJoo Myung Lee, Seung Hun Lee, Doosup Shin, et al.
Diabetes|March 1, 2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 29, 2026
Vessel-Oriented Analysis on the Relationship Between Quantitative-Flow Ratio and Mortality in Patients With Severe Aortic Stenosis and Intermediate Coronary LesionsIginio Colaiori, Luca Paolucci, Fabio Mangiacapra, et al.
Pageof 69

Showing results (271-280 of 685) with videos related to

Sort By:
Pageof 69
Journal of Cardiovascular Translational Research|April 23, 2016
Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI StudyGladys N Janssens, Maarten A H van Leeuwen, Nina W van der Hoeven, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 27, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Trends in Cardiovascular Medicine|November 3, 2021
Optical coherence tomography and coronary revascularization: from indication to procedural optimizationRick Volleberg, Jan-Quinten Mol, Dirk van der Heijden, et al.
European Heart Journal|October 12, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
JACC. Asia|November 7, 2022
Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous Coronary InterventionJoo Myung Lee, Seung Hun Lee, Doosup Shin, et al.
Diabetes|March 1, 2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 29, 2026
Vessel-Oriented Analysis on the Relationship Between Quantitative-Flow Ratio and Mortality in Patients With Severe Aortic Stenosis and Intermediate Coronary LesionsIginio Colaiori, Luca Paolucci, Fabio Mangiacapra, et al.
Pageof 69